Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Efficacy of endoscopic anterior fundoplication with a novel ultrasonic surgical endostapler for gastroesophageal reflux disease: Six-month results from a multicenter prospective trial.

Authors:
Lihua Peng Rong Wan Shengliang Chen Jimin Wu Jing Yang Xiaoxiao Wang Bin Yan Huijun Zhao Fei Pan Yichao Shi Weifeng Wang Jie Ai Yunsheng Yang

Endosc Ultrasound 2022 Jun 8. Epub 2022 Jun 8.

Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.

Background And Objectives: Endoscopic therapy is an option for the treatment of refractory gastroesophageal reflux disease (GERD). We aimed to evaluate the efficacy and safety of transoral incisionless fundoplication with the Medigus ultrasonic surgical endostapler (MUSE™) for refractory GERD.

Materials And Methods: Patients with 2 years of documented GERD symptoms and at least 6 months of proton-pump inhibitors (PPIs) therapy were enrolled in four medical centers from March 2017 to March 2019. The GERD health-related quality of life (HRQL) score, GERD questionnaire score, total acid exposure on esophageal pH probe monitoring, the gastroesophageal flap valve (GEFV), esophageal manometry, and PPIs dosage were compared between the pre- and post-MUSE procedure. All of the side effects were recorded.

Results: A reduction of at least 50% in the GERD-HRQL score was observed in 77.8% (42/54) patients. Most patients 74.1% (40/54) discontinued PPIs and 11.1% (6/54) reported a ≥50% dose reduction. The percentage of patients who had normalized acid exposure time after the procedure was 46.9% (23/49). The existence of hiatal hernia at baseline was negatively correlated with the curative effect. Mild pain was common and resolved within 48 h postprocedure. Serious complications were pneumoperitoneum (one case), mediastinal emphysema combined with pleural effusion (two cases).

Conclusions: Endoscopic anterior fundoplication with MUSE was an effective treatment for refractory GERD, but still needs refinement and improvement in safety aspect. Esophageal hiatal hernia may affect the efficacy of MUSE. (www.chictr.org.cn, ChiCTR2000034350).

Download full-text PDF

Source
http://dx.doi.org/10.4103/EUS-D-21-00244DOI Listing
June 2022

Publication Analysis

Top Keywords

treatment refractory
8
endoscopic anterior
8
anterior fundoplication
8
hiatal hernia
8
acid exposure
8
reflux disease
8
ultrasonic surgical
8
surgical endostapler
8
gastroesophageal reflux
8
gerd
5
wwwchictrorgcn chictr2000034350
4
dose reduction
4
health-related quality
4
reduction percentage
4
quality life
4
hrql score
4
life hrql
4
≥50% dose
4
gerd health-related
4
score gerd
4

Keyword Occurance

Similar Publications

Combined responsive neurostimulation and focal resection for super refractory status epilepticus: a systematic review and illustrative case report.

Authors:
James Mamaril-Davis Meena Vessell Tyler Ball Adriana Palade Christopher Shafer Pedro Aguilar-Salinas Brooks Fowler Emily Mirro Joseph Neimat Vishwanath Sagi Robert W Bina

World Neurosurg 2022 Aug 7. Epub 2022 Aug 7.

Department of Neurosurgery, Banner University Medical Center / The University of Arizona, Phoenix, Arizona. Electronic address:

Objective: Super-refractory status epilepticus (SRSE) is a neurological emergency with high mortality and morbidity. Although medical algorithms are typically effective, when they do fail, options may be limited, and neurosurgical intervention should be considered.

Methods: We report a case of SRSE treated acutely with responsive neurostimulation (RNS) and focal surgical resection after intracranial monitoring. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

A Carrier-free, Dual-Functional Hydrogel Constructed of Antimicrobial Peptide Jelleine-1 and 8Br-cAMP for MRSA Infected Diabetic Wound Healing.

Authors:
Jingjing Zhou Zhaopeng Wang Changyan Yang Hanru Zhang Muhammad Subaan Fareed Yuhang He Jie Su Panpan Wang Zhiqiang Shen Wenjin Yan Kairong Wang

Acta Biomater 2022 Aug 7. Epub 2022 Aug 7.

Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Research Unit of Peptide Science, Chinese Academy of Medical Sciences 2019RU066, Lanzhou University, West Donggang Road 199, Lanzhou, 730000, P. R. China; State Key Laboratory of Veterinary Etiological Biology, College of Veterinary Medicine, Lanzhou University, Lanzhou, 730000, P. R. China. Electronic address:

Bacterial infection and local growth factor deficiency are two of the major causes of the nonunion of diabetic wounds. Antimicrobial peptides (AMPs) are believed to be alternatives to antibiotics against drug-resistant bacterial infections. 8-Bromoadenosine-3', 5'-cyclic monophosphate (8Br-cAMP) can promote cells to secrete growth factors and accelerate cell proliferation. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer.

Authors:
Jashodeep Datta Xizi Dai Anna Bianchi Iago De Castro Silva Siddharth Mehra Vanessa Garrido Purushottam Lamichhane Samara Singh Zhiqun Zhou Austin R Dosch Fanuel Messaggio Yuguang Ban Oliver Umland Peter J Hosein Nagaraj S Nagathihalli Nipun B Merchant

Gastroenterology 2022 Aug 7. Epub 2022 Aug 7.

Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, Miami, FL, USA. Electronic address:

Background: We have shown that reciprocally activated RAS/MEK and JAK/STAT3 pathways mediate therapeutic resistance in pancreatic ductal adenocarcinoma (PDAC), while combined MEK and STAT3 inhibition (MEKi+STAT3i) overcomes such resistance and alters stromal architecture. We now determine if MEKi+STAT3i reprograms the cancer-associated fibroblast (CAF) and immune microenvironment to overcome resistance to immune checkpoint inhibition in PDAC.

Methods: CAF and immune cell transcriptomes in MEKi (trametinib)+STAT3i(ruxolitinib)- vs. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Factors Influencing the Implementation of Prone Positioning During the COVID-19 Pandemic: A Qualitative Study.

Authors:
Chad H Hochberg Mary E Card Bhavna Seth Meeta P Kerlin David N Hager Michelle N Eakin

Ann Am Thorac Soc 2022 Aug 10. Epub 2022 Aug 10.

Johns Hopkins University, Medicine, Baltimore, Maryland, United States.

Rationale: The adoption of prone positioning for patients with acute respiratory distress syndrome (ARDS) has historically been poor. However, in mechanically ventilated patients with COVID-19 ARDS, proning has increased. Understanding the factors influencing this change is important for further expanding and sustaining the use of prone positioning in appropriate clinical settings. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.

Authors:
Shawn J Macha Balakrishna Koneru Trevor A Burrow Charles Zhu Dzmitry Savitski Rakhshanda L Rahman Catherine A Ronaghan Jonas Nance Kristyn McCoy Cody Eslinger C Patrick Reynolds

Cancer Res 2022 Aug 10:OF1-OF14. Epub 2022 Aug 10.

Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.

A subset of cancers across multiple histologies with predominantly poor outcomes use the alternative lengthening of telomeres (ALT) mechanism to maintain telomere length, which can be identified with robust biomarkers. ALT has been reported to be prevalent in high-risk neuroblastoma and certain sarcomas, and ALT cancers are a major clinical challenge that lack targeted therapeutic approaches. Here, we found ALT in a variety of pediatric and adult cancer histologies, including carcinomas. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap